By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010


Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit, LinkedIn and follow us on


Key Statistics

Ownership: Public

Web Site: Amgen
Employees: 20,000
Symbol: AMGN

Company News
FDA Clears Amgen (AMGN) Copy of AbbVie (ABBV)'s Blockbuster Humira 9/26/2016 5:49:14 AM
Another Good Day for Amgen (AMGN) as Repatha Phase III GLAGOV Trial Met Primary, Secondary Endpoints 9/20/2016 7:24:19 AM
Amgen (AMGN), UCB Group (UCBJF.PK)'s Romosozumab Showed Significant Results in Phase III Study 9/19/2016 5:52:37 AM
Dr. Reddy's Laboratories Ltd. (RDY)’s Expands Strategic Collaboration With Amgen (AMGN) In India 9/16/2016 11:22:40 AM
Amgen (AMGN) Presents Positive Data At EHMTIC 2016 Demonstrating Erenumab Significantly Reduces Monthly Migraine Days In Patients With Chronic Migraine 9/16/2016 7:09:43 AM
Amgen (AMGN) Receives Positive CHMP Opinion For Parsabiv (Etelcalcetide) For The Treatment Of Secondary Hyperparathyroidism In Adult Patients With Chronic Kidney Disease On Hemodialysis 9/16/2016 6:43:00 AM
Amgen (AMGN) To Webcast Investor Call 9/14/2016 3:23:48 PM
Amgen (AMGN) To Present At The Bank of America (BAC) Merrill Lynch Global Healthcare Conference 9/14/2016 8:47:58 AM
Apobiologix Announces Victory Over Amgen (AMGN) In Biosimilar Patent Case 9/9/2016 11:04:39 AM
Amgen (AMGN) To Present At The Morgan Stanley (MST) Global Healthcare Conference 9/9/2016 9:24:28 AM